O'Neill Gilmore Neil
CIK 0001742084
CEODirector
Filings
18
Latest Mar 16, 2026
Issuers covered
3
Showing
18 of 18
Page 1
Track record
10 of 10 open-market trades scored (100% price coverage). Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 10 | 70% | +1.6% | +12.8% | +36.4% | -56.8% |
| 90 days | 10 | 70% | +6.6% | +12.2% | +43.4% | -68.1% |
| 180 days | 9 | 56% | +8.3% | +10.6% | +61.9% | -45.0% |
| 365 days | 7 | 57% | +16.6% | +28.0% | +77.6% | -52.7% |
Issuers
Companies where O'Neill Gilmore Neil has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| EDIT | Editas Medicine, Inc. | 14 | Mar 16, 2026 |
| UBX | Unity Biotechnology, Inc. | 3 | Jun 21, 2024 |
| APTX | Aptinyx Inc. | 1 | May 31, 2022 |
All filings
18 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|